NCT00772811View on ClinicalTrials.gov

Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

September 30, 2010

Study Completion Date

December 31, 2010

Conditions
Chronic Lymphocytic LeukemiaLymphomaMultiple Myeloma
Interventions
DRUG

Flu-Mel

"* Fludarabine and Melphalan will be infused intravenously over 30 minutes in D5W 100 mL.~* Melphalan will be administered following the completion of Fludarabine infusion at day -2."

Trial Locations (1)

138-736

Asan Medical Center, Seoul

All Listed Sponsors
lead

Cooperative Study Group A for Hematology

NETWORK

NCT00772811 - Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma | Biotech Hunter | Biotech Hunter